Betnova 0.1% (Cream)
15 gm tube: ৳ 33.60
Medicine Details
| Category | Details |
|---|---|
| Generic | Betamethasone valerate |
| Company | Nipro jmi pharma ltd |
| Also available as |
Indications
- Eczema in children and adults including atopic
- Infantile and descoid eczema
- Prurigo nodularis
- Psoriasis (excluding wide spread plaque psoriasis)
- Neurodermatoses including lichen simplex and lichen planus
- Seborrhoic dermatitis
- Contact sensitivity reaction
- Discoid lupus erythematoses and may be used as adjunct to systemic steroid therapy in generalized erythroderma
Pharmacology
- Synthetic adrenocorticosteroid
- Glucocorticoid in nature
- Anti-inflammatory
- Antipruritic
- Vasoconstrictive activity
- Effective for dermatological use
- Absorbed from the skin
- Percutaneous absorption from the skin
- Occlusive dressings increase absorption
Dosage & Administration
- Apply sparingly to the affected area two or three times daily until improvement occurs
- Then twice daily or less
- Usual maximum duration of therapy is three weeks
Interaction
- No significant drug interactions reported with Betnova Cream/Ointment
Contraindications
- Hypersensitivity to any of the ingredients in the preparation
- Rosaceae & acne vulgaris
- Perioral dermatitis, perianal & genital pruritis
- Viral infections of the skin, e.g. herpes simplex & chicken pox
- Primary infected skin lesions caused by fungi or bacteria
- Dermatoses in children under one year of age
Side Effects
- Dryness
- Itching
- Burning
- Skin thinning
- Local irritation
- Features of hypercorticolism
- Telangiectasia
- Striae
- Skin atrophy
- Hypertrichosis
- Change in pigmentation
- Secondary infection
- Perioral dermatitis
- Allergic contact dermatitis
- Maceration of the skin
- Acneform eruption
- Exacerbation of symptoms
Pregnancy & Lactation
- Should not be used extensively in pregnancy
Precautions & Warnings
- Well tolerated, but stop application if signs of hypersensitivity appear
- Avoid long term continuous topical therapy, particularly in children as adrenal suppression may occur even without occlusion
- Sufficient systemic absorption may occur when treating extensive areas
- Atrophic changes may appear after prolonged treatment
- Care needed to ensure the preparation does not enter the eye if applied to the eyelids
Therapeutic Class
- Corticosteroid
Storage Conditions
- Keep below 30°C temperature
- Away from light & moisture
- Keep out of the reach of children